Lincoln

More bishops call for Notre Dame to drop appointment of pro-abortion professor #Catholic Nearly half a dozen more bishops have joined the growing backlash against the University of Notre Dame over its controversial appointment of an outspoken abortion advocate to lead a university department.Fort Wayne-South Bend, Indiana, Bishop Kevin Rhoades on Feb. 11 issued a statement criticizing the university for appointing global affairs Professor Susan Ostermann as director of the school’s Liu Institute for Asia and Asian Studies.Three of Rhoades’ fellow bishops quickly backed the prelate’s remarks, voicing support on social media and calling on the university to drop Ostermann’s nomination. On Feb. 12, five more bishops commended Rhoades for his statement and expressed hope that the historic Catholic university would rescind the appointment. Gallup, New Mexico, Bishop James Wall praised Rhoades for his stance, with the western U.S. prelate offering a quote attributed to Pope Leo XIV: “We cannot build a just society if we discard the weakest, whether the child in the womb or the old man in his fragility, for both are gifts from God.”TweetSan Francisco Archbishop Salvatore Cordileone also thanked Rhoades for “speaking up.” “Holy Mary, Mother of God and Our Lady, pray for the university that bears your name,” Cordileone said. TweetGreen Bay, Wisconsin, Bishop David Ricken, meanwhile, wrote: “I fully affirm and stand in solidarity with my brother bishop [Rhoades].” He said Rhoades spoke “with clarity, courage, and fidelity to the Church’s mission.”“[L]et us turn with confidence to our Blessed Mother. Our Lady, pray for us! You are our loving Mother — we love you and entrust this to your Immaculate Heart,” Ricken wrote.TweetMadison, Wisconsin, Bishop Donald Hying described Rhoades’ statement as “a profound reflection on human dignity and the culture of life.”Tweet“We pray that all of our educational institutions support Catholic teaching, especially regarding human life,” he said. Lincoln, Nebraska, Bishop James Conley said he “stand[s] in support of Bishop Rhoades” while sharing his concern over the appointment. “Catholic institutions must faithfully reflect the truth of the dignity of every human life in both their mission and their leadership,” he said. TweetThe University of Notre Dame has continued to stand by its appointment of Ostermann, whose post is scheduled to take effect July 1. Rhoades on Feb. 11 said there is “still time [for the university] to make things right.”Ostermann, meanwhile, told the National Catholic Register in January that her role at the school “is to support the diverse research of our scholars and students, not to advance a personal political agenda.”The professor said she “respect[s] Notre Dame’s institutional position on the sanctity of life at every stage” and described herself as “inspired by the university’s focus on integral human development, which calls us to promote the dignity and flourishing of every person.”

More bishops call for Notre Dame to drop appointment of pro-abortion professor #Catholic Nearly half a dozen more bishops have joined the growing backlash against the University of Notre Dame over its controversial appointment of an outspoken abortion advocate to lead a university department.Fort Wayne-South Bend, Indiana, Bishop Kevin Rhoades on Feb. 11 issued a statement criticizing the university for appointing global affairs Professor Susan Ostermann as director of the school’s Liu Institute for Asia and Asian Studies.Three of Rhoades’ fellow bishops quickly backed the prelate’s remarks, voicing support on social media and calling on the university to drop Ostermann’s nomination. On Feb. 12, five more bishops commended Rhoades for his statement and expressed hope that the historic Catholic university would rescind the appointment. Gallup, New Mexico, Bishop James Wall praised Rhoades for his stance, with the western U.S. prelate offering a quote attributed to Pope Leo XIV: “We cannot build a just society if we discard the weakest, whether the child in the womb or the old man in his fragility, for both are gifts from God.”TweetSan Francisco Archbishop Salvatore Cordileone also thanked Rhoades for “speaking up.” “Holy Mary, Mother of God and Our Lady, pray for the university that bears your name,” Cordileone said. TweetGreen Bay, Wisconsin, Bishop David Ricken, meanwhile, wrote: “I fully affirm and stand in solidarity with my brother bishop [Rhoades].” He said Rhoades spoke “with clarity, courage, and fidelity to the Church’s mission.”“[L]et us turn with confidence to our Blessed Mother. Our Lady, pray for us! You are our loving Mother — we love you and entrust this to your Immaculate Heart,” Ricken wrote.TweetMadison, Wisconsin, Bishop Donald Hying described Rhoades’ statement as “a profound reflection on human dignity and the culture of life.”Tweet“We pray that all of our educational institutions support Catholic teaching, especially regarding human life,” he said. Lincoln, Nebraska, Bishop James Conley said he “stand[s] in support of Bishop Rhoades” while sharing his concern over the appointment. “Catholic institutions must faithfully reflect the truth of the dignity of every human life in both their mission and their leadership,” he said. TweetThe University of Notre Dame has continued to stand by its appointment of Ostermann, whose post is scheduled to take effect July 1. Rhoades on Feb. 11 said there is “still time [for the university] to make things right.”Ostermann, meanwhile, told the National Catholic Register in January that her role at the school “is to support the diverse research of our scholars and students, not to advance a personal political agenda.”The professor said she “respect[s] Notre Dame’s institutional position on the sanctity of life at every stage” and described herself as “inspired by the university’s focus on integral human development, which calls us to promote the dignity and flourishing of every person.”

The university has endured sustained backlash for nominating the outspoken abortion advocate to lead an academic department.

Read More
Pro-life movement has mixed reaction after Trump’s first year of second term #Catholic 
 
 Participants in a pro-life rally hold signs in front of the Lincoln Memorial in Washington, D.C., on June 24, 2023, at a rally marking the first anniversary of the Supreme Court's Dobbs decision that overturned Roe v. Wade. | Credit: Joseph Portolano/EWTN News

Jan 20, 2026 / 14:37 pm (CNA).
Members of the pro-life movement have mixed thoughts on the first year of President Donald Trump’s second term, noting many wins early into his presidency but a number of shortfalls as time has gone by.Some wins include defunding Planned Parenthood, walking back some of President Joe Biden’s initiatives, and removing foreign aid funding for organizations that promote abortion. However, a lack of action on chemical abortions and weakened rhetoric surrounding taxpayer-funded abortions are causing concern.A notable pro-life win was included in the tax overhaul bill signed by Trump in July, which cut off all Medicaid reimbursements for organizations that provide a large number of abortions, such as Planned Parenthood.Amid funding cuts, nearly 70 Planned Parenthood affiliates shut down. The administration also initially cut off Title X family planning grants from the abortion giant, but those have resumed.The president pardoned pro-life protesters convicted of violating the Freedom of Access to Clinic Entrances (FACE) Act and blocked foreign aid from supporting organizations that promote abortion. He rescinded several policies from the Biden administration, including one that paid Pentagon workers to travel for abortions. He also established strong conscience protections for pro-life doctors.“Right out the gate, we saw some progress on the pro-life issue,” Kelsey Pritchard, a spokesperson for Susan B. Anthony Pro-Life America (SBA), told EWTN.Yet, she cautioned: “We have also not seen progress in the one area that matters the most — and that’s on abortion drugs.”Health Secretary Robert F. Kennedy Jr. launched a study into the safety of the abortion pill mifepristone in September 2025, but so far no action has been taken to curtail the drug. Rather, the Food and Drug Administration (FDA) went in the opposite direction, approving a generic version of mifepristone later that same month.Pritchard said that move was “the opposite of what they should have done,” and referred to the generic mifepristone as “a new kill pill to increase the number of abortions that are done in this country.”She said Kennedy’s promised study has “absolutely been moving too slow” and added that there is no confirmation it even began or is taking place. SBA called for FDA Commissioner Marty Makary to be fired following allegations he was “slow-walking the report for political reasons,” she said.Trump has said abortion should be regulated by the states, but Pritchard warned “those [pro-life] laws can’t be in effect at all, really, when mail-order abortion happens with the abortion drugs.”“They’re allowing [California Gov.] Gavin Newsom and [New York Gov.] Kathy Hochul and their blue state friends to completely nullify the pro-life laws in states like Texas and Florida,” she said.Joseph Meaney, a senior ethicist at the National Catholic Bioethics Center, similarly said “the delay in the promised review of the rushed process in which mifepristone was approved as an abortion drug by the FDA has frustrated pro-lifers.”“When the FDA approved a second generic version of mifepristone, … it highlighted the lack of progress in fighting the leading means of doing abortions in the [United States],” he said.Trump also began to waver on taxpayer-funded abortions early in 2026, asking Republicans to be “flexible” on the Hyde Amendment amid negotiations on extending health care subsidies for the Affordable Care Act. Trump later unveiled “The Great Healthcare Plan” and said the White House intends to negotiate with Congress to ensure pro-life protections.Pritchard called taxpayer-funded abortion “a very basic red line” and said it’s “concerning to see Republicans back away from something so basic.”She warned Republicans to not take pro-life voters for granted in the upcoming midterms, saying “you’ll lose the elections and we won’t have the majority of Congress” without pro-life voters.“You must remain the pro-life party or you will lose the midterms if you decide to bow to the pro-death Democrat agenda,” Pritchard said.Meaney said there is “a widespread feeling that the second Trump administration has seemed to deprioritize issues important to the pro-life community,” adding he has “seen calls for pro-life groups to ‘flex their muscles’ and show that they cannot be taken for granted.”However, he said the shortfalls “should not obscure the fact that the Trump administration has rolled back the Biden-era pro-abortion measures internationally and domestically.”“It even achieved a temporary defunding of Planned Parenthood domestically in legislation,” he said. “The federal government no longer funds research on fetal tissues and defends the conscience rights of health care professionals and others robustly.”Trump also signed an executive order that directed departments and agencies to boost access to and reduce the cost of in vitro fertilization (IVF). The Catholic Church opposes IVF, which results in the destruction of human embryos, ending human lives.

Pro-life movement has mixed reaction after Trump’s first year of second term #Catholic Participants in a pro-life rally hold signs in front of the Lincoln Memorial in Washington, D.C., on June 24, 2023, at a rally marking the first anniversary of the Supreme Court's Dobbs decision that overturned Roe v. Wade. | Credit: Joseph Portolano/EWTN News Jan 20, 2026 / 14:37 pm (CNA). Members of the pro-life movement have mixed thoughts on the first year of President Donald Trump’s second term, noting many wins early into his presidency but a number of shortfalls as time has gone by.Some wins include defunding Planned Parenthood, walking back some of President Joe Biden’s initiatives, and removing foreign aid funding for organizations that promote abortion. However, a lack of action on chemical abortions and weakened rhetoric surrounding taxpayer-funded abortions are causing concern.A notable pro-life win was included in the tax overhaul bill signed by Trump in July, which cut off all Medicaid reimbursements for organizations that provide a large number of abortions, such as Planned Parenthood.Amid funding cuts, nearly 70 Planned Parenthood affiliates shut down. The administration also initially cut off Title X family planning grants from the abortion giant, but those have resumed.The president pardoned pro-life protesters convicted of violating the Freedom of Access to Clinic Entrances (FACE) Act and blocked foreign aid from supporting organizations that promote abortion. He rescinded several policies from the Biden administration, including one that paid Pentagon workers to travel for abortions. He also established strong conscience protections for pro-life doctors.“Right out the gate, we saw some progress on the pro-life issue,” Kelsey Pritchard, a spokesperson for Susan B. Anthony Pro-Life America (SBA), told EWTN.Yet, she cautioned: “We have also not seen progress in the one area that matters the most — and that’s on abortion drugs.”Health Secretary Robert F. Kennedy Jr. launched a study into the safety of the abortion pill mifepristone in September 2025, but so far no action has been taken to curtail the drug. Rather, the Food and Drug Administration (FDA) went in the opposite direction, approving a generic version of mifepristone later that same month.Pritchard said that move was “the opposite of what they should have done,” and referred to the generic mifepristone as “a new kill pill to increase the number of abortions that are done in this country.”She said Kennedy’s promised study has “absolutely been moving too slow” and added that there is no confirmation it even began or is taking place. SBA called for FDA Commissioner Marty Makary to be fired following allegations he was “slow-walking the report for political reasons,” she said.Trump has said abortion should be regulated by the states, but Pritchard warned “those [pro-life] laws can’t be in effect at all, really, when mail-order abortion happens with the abortion drugs.”“They’re allowing [California Gov.] Gavin Newsom and [New York Gov.] Kathy Hochul and their blue state friends to completely nullify the pro-life laws in states like Texas and Florida,” she said.Joseph Meaney, a senior ethicist at the National Catholic Bioethics Center, similarly said “the delay in the promised review of the rushed process in which mifepristone was approved as an abortion drug by the FDA has frustrated pro-lifers.”“When the FDA approved a second generic version of mifepristone, … it highlighted the lack of progress in fighting the leading means of doing abortions in the [United States],” he said.Trump also began to waver on taxpayer-funded abortions early in 2026, asking Republicans to be “flexible” on the Hyde Amendment amid negotiations on extending health care subsidies for the Affordable Care Act. Trump later unveiled “The Great Healthcare Plan” and said the White House intends to negotiate with Congress to ensure pro-life protections.Pritchard called taxpayer-funded abortion “a very basic red line” and said it’s “concerning to see Republicans back away from something so basic.”She warned Republicans to not take pro-life voters for granted in the upcoming midterms, saying “you’ll lose the elections and we won’t have the majority of Congress” without pro-life voters.“You must remain the pro-life party or you will lose the midterms if you decide to bow to the pro-death Democrat agenda,” Pritchard said.Meaney said there is “a widespread feeling that the second Trump administration has seemed to deprioritize issues important to the pro-life community,” adding he has “seen calls for pro-life groups to ‘flex their muscles’ and show that they cannot be taken for granted.”However, he said the shortfalls “should not obscure the fact that the Trump administration has rolled back the Biden-era pro-abortion measures internationally and domestically.”“It even achieved a temporary defunding of Planned Parenthood domestically in legislation,” he said. “The federal government no longer funds research on fetal tissues and defends the conscience rights of health care professionals and others robustly.”Trump also signed an executive order that directed departments and agencies to boost access to and reduce the cost of in vitro fertilization (IVF). The Catholic Church opposes IVF, which results in the destruction of human embryos, ending human lives.


Participants in a pro-life rally hold signs in front of the Lincoln Memorial in Washington, D.C., on June 24, 2023, at a rally marking the first anniversary of the Supreme Court's Dobbs decision that overturned Roe v. Wade. | Credit: Joseph Portolano/EWTN News

Jan 20, 2026 / 14:37 pm (CNA).

Members of the pro-life movement have mixed thoughts on the first year of President Donald Trump’s second term, noting many wins early into his presidency but a number of shortfalls as time has gone by.

Some wins include defunding Planned Parenthood, walking back some of President Joe Biden’s initiatives, and removing foreign aid funding for organizations that promote abortion. However, a lack of action on chemical abortions and weakened rhetoric surrounding taxpayer-funded abortions are causing concern.

A notable pro-life win was included in the tax overhaul bill signed by Trump in July, which cut off all Medicaid reimbursements for organizations that provide a large number of abortions, such as Planned Parenthood.

Amid funding cuts, nearly 70 Planned Parenthood affiliates shut down. The administration also initially cut off Title X family planning grants from the abortion giant, but those have resumed.

The president pardoned pro-life protesters convicted of violating the Freedom of Access to Clinic Entrances (FACE) Act and blocked foreign aid from supporting organizations that promote abortion. He rescinded several policies from the Biden administration, including one that paid Pentagon workers to travel for abortions. He also established strong conscience protections for pro-life doctors.

“Right out the gate, we saw some progress on the pro-life issue,” Kelsey Pritchard, a spokesperson for Susan B. Anthony Pro-Life America (SBA), told EWTN.

Yet, she cautioned: “We have also not seen progress in the one area that matters the most — and that’s on abortion drugs.”

Health Secretary Robert F. Kennedy Jr. launched a study into the safety of the abortion pill mifepristone in September 2025, but so far no action has been taken to curtail the drug. Rather, the Food and Drug Administration (FDA) went in the opposite direction, approving a generic version of mifepristone later that same month.

Pritchard said that move was “the opposite of what they should have done,” and referred to the generic mifepristone as “a new kill pill to increase the number of abortions that are done in this country.”

She said Kennedy’s promised study has “absolutely been moving too slow” and added that there is no confirmation it even began or is taking place. SBA called for FDA Commissioner Marty Makary to be fired following allegations he was “slow-walking the report for political reasons,” she said.

Trump has said abortion should be regulated by the states, but Pritchard warned “those [pro-life] laws can’t be in effect at all, really, when mail-order abortion happens with the abortion drugs.”

“They’re allowing [California Gov.] Gavin Newsom and [New York Gov.] Kathy Hochul and their blue state friends to completely nullify the pro-life laws in states like Texas and Florida,” she said.

Joseph Meaney, a senior ethicist at the National Catholic Bioethics Center, similarly said “the delay in the promised review of the rushed process in which mifepristone was approved as an abortion drug by the FDA has frustrated pro-lifers.”

“When the FDA approved a second generic version of mifepristone, … it highlighted the lack of progress in fighting the leading means of doing abortions in the [United States],” he said.

Trump also began to waver on taxpayer-funded abortions early in 2026, asking Republicans to be “flexible” on the Hyde Amendment amid negotiations on extending health care subsidies for the Affordable Care Act. Trump later unveiled “The Great Healthcare Plan” and said the White House intends to negotiate with Congress to ensure pro-life protections.

Pritchard called taxpayer-funded abortion “a very basic red line” and said it’s “concerning to see Republicans back away from something so basic.”

She warned Republicans to not take pro-life voters for granted in the upcoming midterms, saying “you’ll lose the elections and we won’t have the majority of Congress” without pro-life voters.

“You must remain the pro-life party or you will lose the midterms if you decide to bow to the pro-death Democrat agenda,” Pritchard said.

Meaney said there is “a widespread feeling that the second Trump administration has seemed to deprioritize issues important to the pro-life community,” adding he has “seen calls for pro-life groups to ‘flex their muscles’ and show that they cannot be taken for granted.”

However, he said the shortfalls “should not obscure the fact that the Trump administration has rolled back the Biden-era pro-abortion measures internationally and domestically.”

“It even achieved a temporary defunding of Planned Parenthood domestically in legislation,” he said. “The federal government no longer funds research on fetal tissues and defends the conscience rights of health care professionals and others robustly.”

Trump also signed an executive order that directed departments and agencies to boost access to and reduce the cost of in vitro fertilization (IVF). The Catholic Church opposes IVF, which results in the destruction of human embryos, ending human lives.

Read More
Picture of the day





4″x3″ slide depicting John Wilkes Booth leaning forward to shoot President Abraham Lincoln as he watches Our American Cousin at Ford’s Theater in Washington, D.C.. The assassination occurred on this date 160 years ago.
 #ImageOfTheDay
Picture of the day
4″x3″ slide depicting John Wilkes Booth leaning forward to shoot President Abraham Lincoln as he watches Our American Cousin at Ford’s Theater in Washington, D.C.. The assassination occurred on this date 160 years ago.
Read More